Faculty 2015–2016 Cycle 8

Washington, DC

The American Course on Drug Development and Regulatory Sciences (ACDRS) teaching faculty are science-driven and highly experienced international faculty members with a network of experts in pharmaceutical medicine, medical product development, and regulatory sciences.

Name Affiliation Location
Charles Albright, MD, PhD Merck and Co., Inc. New York, NY
Ramsey Baghdadi Prevision Policy Washington, DC
Robert Ball, MD, MPH, ScM US Food and Drug Administration Silver Spring, MD
Scott Berry, PhD Berry Consultants Austin, TX
Bruce S. Binkowitz, PhD Merck and Co., Inc. Rahway, NJ
Lauren Black, PhD Charles River Laboratories Baltimore, MD
Terrence Blaschke, MD University of California, San Francisco San Francisco, CA
Sir Alasdair Breckenridge, FRSE, FMedSci former MHRA chairman London, United Kingdom
Joseph Caminiti H4B Catapult Hamilton, NJ
Gregory Campbell, PhD Consultant Washington, DC
Louis R. Cantilena, MD, PhD Medical Strategic Initiatives, LLC Bethesda, MD
Tim Coté, MD, MPH Coté Orphan Consulting Washington, DC
Theodore Danoff, MD, PhD Clarus Therapeutics Philadelphia, PA
Patricia Evans, PhD Independent Consultant Los Altos, CA
David W. Feigal, Jr, MD, MPH Arizona State University School of Law San Francisco, CA
Leslie C. Floren, PharmD University of California, San Francisco San Francisco, CA
Joshua Galanter, MD University of California, San Francisco San Francisco, CA
Mark J. Goldberger, MD, MPH Consultant Washington, DC
Charles T. Gombar, PhD Bill and Melinda Gates Foundation Seattle, WA
Charles Grudzinskas, PhD NDA Partners, LLC Annapolis, MD
David Hermann, PharmD Great Lakes Drug Development / Certara Detroit, MI
Christopher Horvath, DVM, MS, DACVP bluebird bio Cambridge, MA
Florence Houn, MD, MPH, FACP Consultant Washington, DC
John Jenkins, MD US Food and Drug Administration Silver Spring, MD
Diane K. Jorkasky, MD, FACP Complexa Inc. Philadelphia, PA
Kenneth Kaitin, PhD Tufts University Boston, MA
Jack Kloeber, PhD Kromite Philadelphia, PA
Zili Li, MD, MPH Bill and Melinda Gates Foundation Seattle, WA
Christopher Lipinski, PhD Melior Discover Waterford, CT
Murray M. Lumpkin, MD, MSc Bill and Melinda Gates Foundation Seattle, WA
David Macarios, MBA Lifecell Corporation Bridgewater, NJ
Diane Mould, PhD Projections Research Phoenixville, PA
Bernard Munos, MBA InnoThink Center for Research in Biomedical Innovation Indianopolis, IN
Mark Noguchi, MBA Genentech South San Francisco, CA
Ralph O'Brien, PhD Case Western Reserve University (retired) Cleveland, OH
Mary Parks, MD US Food and Drug Administration Silver Spring, MD
Carl C. Peck, MD University of California, San Francisco San Luis Obispo, CA
Saileta Prabhu, PhD Genentech South San Francisco, CA
William Prucka Eli Lilly & Company Indianapolis, IN
Joseph Rappon, OD, MS, FAAO Alcon Atlanta, GA
Frank Rockhold, PhD GlaxoSmithKline Raleigh-Durham, NC
Malcolm Rowland, PhD, DSc University of California, San Francisco London, United Kingdom
Stephen J. Ruberg, PhD Eli Lilly and Company Indianapolis, IN
Hansjorg Sauer, MS, PhD, JD Biotechnology Industry Organization Washington, DC
David Savello, PhD NDA Partners LLC Palo Alto, CA
Robert Seltzer, MBA Care Capital Princeton, NJ
Vikram Sinha, PhD US Food and Drug Administration Silver Spring, MD
Zachary Skrivanek Eli Lilly and Company Indianapolis, IN
Brian Smith, PhD Novartis Boston, MA/td>
Dominic G. Spinella, PhD Amgen Thousand Oaks, CA
S. Aubrey Stoch, MD Merck and Co., Inc. Rahway, NY
Norman Stockbridge, MD US Food and Drug Administration Silver Spring, MD
Karthik Venkatakrishnan, PhD FCP Takeda Deerfield, IL
Paolo Vicini, PhD MedImmune Cambridge, UK
Kristina Vlaovic, MPH Halozyme San Diego, CA
Russ Wada, PhD Quantitative Solutions Menlo Park, CA
Yaning Wang, PhD US Food and Drug Administration Silver Spring, MD
John Warren, JD McDermott Will & Emery LLP Washington, DC

Faculty in other years

See Faculty.